Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to...

Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95

Audrey Simon, Michel Peoch, Philippe Casassus, Eric Deconinck, Philippe Colombat, Bernard Desablens, Olivier Tournilhac, Houchingue Eghbali, Charles Foussard, Jerome Jaubert, Jean Pierre Vilque, Jean
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
151
Year:
2010
Language:
english
Pages:
8
DOI:
10.1111/j.1365-2141.2010.08329.x
File:
PDF, 237 KB
english, 2010
Conversion to is in progress
Conversion to is failed